CTOs on the Move

Dallas Endoscopy Center

www.dec-tx.com

 
Dallas Endoscopy Center is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.dec-tx.com
  • 5327 N Central Expy Ste 200
    Dallas, TX USA 75205
  • Phone: 214.520.8235

Executives

Name Title Contact Details

Similar Companies

Shape Up The Nation

Shape Up The Nation is the first corporate wellness company focused on leveraging the power of trusted social networks to promote healthy living.

Weber and Weber International GmbH and Co.

Weber and Weber International GmbH and Co. is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PresenceLearning

PresenceLearning is the leading provider of online special education services for early intervention and K-12 students in the United States. We provide “anytime, anywhere” access to a network of more than 700 fully licensed, highly qualified clinicians who work face-to-face with students via live videoconferencing using our proprietary platform and instructional activities. Since our founding in 2009, we have delivered more than 1,000,000 sessions of teletherapy to hundreds of school districts, charter schools, and virtual school organizations across the United States. And we`re not stopping there. The shortage of Speech-Language Pathologists (SLPs), Occupational Therapists (OTs), and Mental Health Professionals (MHPs) is reaching crisis proportions, innovative modes of delivery have become essential for providing access to therapeutic services. Our dedicated team of employees is committed to seeing children thrive via the growing online therapy revolution.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.

Medterra

Medterra takes pride in providing our customers with the highest quality pure CBD, grown and processed in the USA.